| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.070 | - | - | - | 3.740 | 7.157 | 13.308 | 15.174 | 12.817 | 15.273 |
| Total Income - EUR | 7.070 | - | - | - | 3.740 | 7.762 | 13.308 | 15.174 | 12.817 | 15.273 |
| Total Expenses - EUR | 2.625 | - | - | - | 5.267 | 9.180 | 15.135 | 17.733 | 11.750 | 14.796 |
| Gross Profit/Loss - EUR | 4.445 | - | - | - | -1.526 | -1.418 | -1.828 | -2.559 | 1.067 | 476 |
| Net Profit/Loss - EUR | 4.233 | - | - | - | -1.564 | -1.464 | -1.961 | -2.691 | 939 | 18 |
| Employees | 1 | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Medivera S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | - | - | - | 0 | 66 | 0 | 0 | 0 | 617 |
| Current Assets | 19.530 | - | - | - | 10.823 | 8.923 | 1.738 | 363 | 937 | 2.007 |
| Inventories | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 315 | - | - | - | 0 | 83 | 270 | 0 | 494 | 590 |
| Cash | 19.216 | - | - | - | 10.823 | 8.841 | 1.467 | 363 | 444 | 1.416 |
| Shareholders Funds | 19.208 | - | - | - | 10.549 | 8.885 | 1.052 | -1.635 | -691 | -669 |
| Social Capital | 45 | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 322 | - | - | - | 274 | 105 | 685 | 1.998 | 1.629 | 3.293 |
| Income in Advance | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medivera S.r.l.